Novartis Ireland Limited
Lobbying activity
The following activities occurred for this specific Subject Matter Area.
Email (2-5)
Making the deputies aware of recent press coverage on radioligands and events (2) at the EU parliament.
Asking for support that the healthcare system is ready for new novel treatments like radioligand therapies which are used to treat cancer. Also employing guideline-directed therapy ie "rapid up-titration" for heart failure patients which would reduce the need for so many outpatient appointments.
Meeting (1)
Asking for support that the healthcare system in Ireland is ready for new novel treatments like radioligand therapies which are used to treat cancer. Also employing guideline-directed therapy ie "rapid up-titration" for heart failure patients which would reduce the need for so many outpatient appointments.
Designated public officials lobbied
The following DPOs were lobbied during this return period on this specific Subject Matter Area. These DPOs were involved in at least one of the Lobbying Activities listed above, but not necessarily all of them. As returns are specific to a Subject Matter Area the above Lobbying Activities may be associated with multiple returns.